Commit To Purchase OncoMed Pharmaceuticals At $10, Earn 29.6% Annualized Using Options
July 27, 2016 at 11:46 AM EDT
Investors considering a purchase of OncoMed Pharmaceuticals Inc. (OMED) stock, but tentative about paying the going market price of $12.31/share, might benefit from considering selling puts among the alternative strategies at their disposal..